Table 1—

Clinical characteristics of the randomization groups

Insulin pump groupInsulin injection group
Characteristic
n3940
Males21 (54)21 (53)
Age (years)36.2 ± 10.337.3 ± 10.6
Diabetes duration (years)17.6 ± 9.818.0 ± 9.4
Smoking18 (46.2)26 (65.0)
Weight (kg)77.3 ± 13.679.8 ± 13.5
Retinopathy19 (48.7)17 (42.5)
Nephropathy
 Microalbuminuria11 (28.2)8 (20.0)
 Proteinuria4 (10.2)4 (10.0)
Neuropathy4 (10.2)6 (15.0)
HbA1c (%)9.27 ± 1.49.25 ± 1.4
Mild hypoglycemic episodes (n/patient-week)2.13 ± 2.051.97 ± 1.53
Insulin use (units · kg−1 · 24 h−1)0.90 ± 0.280.88 ± 0.39
SD glucose self measurement4.57 ± 1.664.85 ± 1.70
SF-36 general health61.4 ± 20.559.8 ± 37.0
SF-36 mental health80.0 (64.5, 84.0)78.0 (63.0, 92.0)
DTSQ28.8 ± 3.927.4 ± 4.9
  • Data are n (%), means ± SD, or median (25th, 75th percentiles). DTSQ, Diabetes Treatment Satisfaction Questionnaire.